OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 21, 2015
A Federal circuit appeals court ruled that a biosimilar manufacturer will have to wait 6 months after FDA approval to commercially launch its medication.
July 16, 2015
GSK accelerates delivery timeline for US quadrivalent flu vaccine.
July 15, 2015
Improved characterization of twin-screw extrusion enables increasing use in pharmaceutical manufacturing.
July 14, 2015
The new sizes follow the 2014 launch of the company’s fully disposable purifier.
July 13, 2015
The European Medicines Agency reviews the safety of human papillomavirus vaccines.
July 09, 2015
Sepha's VisionScan Max can leak-test full production batches of blister packs.
Teva has launched the generic version of almotriptan malate (Axert), 6.25 mg and 12.5 mg, in the United States.
July 07, 2015
Vacuum-conveying conditions for powders and other free-flowing solid forms can be simulated in Volkmann's new laboratory.
A study now underway on vaccine manufacturing examines the effects of focusing on consistency during manufacturing, instead of post-production testing.
FDA orders unapproved prescription ear drop products with active ingredients removed from the market.